Skip to main content
OpenTrials
Completed

NCT Number: NCT03547440

T1DM Clinical Onset and Progression in Paediatric Population

Diabetes Mellitus Type I is the chronic metabolic disease of childhood with the highest incidence in developed countries. Over the past 10 years the incidence of diabetes has been increased especially in immigrants children. The objective of the investigator's project is to evaluate factors that influence the T1DM course in immigrant and Italian children through an analysis of the relationship between socio-cultural determinants, lifestyles and metabolic control. The study population will consist of 100 children with first diagnosis of T1DM divided into two cohorts (Italian and immigrant children). The project consists in a follow-up of 18 months from first visit and will include laboratory tests, two questionnaires and determination of a microbiological indicator of the microbiota and levels of 25-hydroxyvitamin D. The research hypothesis is that the two groups of study population show a different metabolic control of diabetes due to differences in access to care, compliance to therapy and type of nutrition.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 14 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pediatric Clinic - Hospital "Maggiore della Carità" of Novara, Novara, Italy

Loading trial locations.

About this study

Over the past ten years a contribution to the increasing incidence of T1DM is derived from children of foreign origin. As many studies confirmed environmental factors are involved in the onset and development of T1DM: type of nutrition, infections, perinatal events, characteristics of the microbial flora, 25-hydroxyvitamin D levels and early exposure to certain foods. Recent research has disclosed a tight connection between gut microbes, host metabolism and utilization and storage of energy. For this reason the microbiota could be implicated also into the diabetes ongoing. Methanobrevibacter smithii is the dominant methanogen in both the distal colon of individuals in health and disease. Some studies reported that immigrant children have a less efficient metabolic control in comparison to age-matched Italian children, thus identifying the different ethnic background as a risk factor for quality of life: a younger age at T1DM diagnosis is frequently observed in immigrant children, which may have also an increased risk of nutritional problems related to dietary habits, social disadvantage and poverty.

The project will make a comparative assessment in the two populations (italian and immigrant children). The research hypothesis is that the two analysed groups show a different metabolic control of diabetes due to differences in access to care, in compliance to therapy and in type of nutrition.

Specific Aim:

  • Estimate any discrepancies in the course of T1DM among the two populations by assessing the modality of hospital admission (ordinary or emergency) and the structures involved.
  • Evaluate the quantity range of a microbiological indicator of intestinal microbial flora, (Methanobrevibacter smithii) determined by molecular techniques on stool samples and the levels of 25-hydroxyvitamin D in serum. That difference will be evaluated on immigrants and non-immigrants diabetic children and on a control group of healthy children.
  • Estimate of the main outcomes of two T1DM populations (glycated hemoglobin, number of hospitalizations for acute events with the calculation of hospital days per year, U insulin / kg / day, dose of C-peptide as an expression of residual pancreatic function) and their compliance to therapy and prescriptions (frequency of tests and visits, adherence to insulin therapy, dietary lifestyles).

Case-control at the onset of Italian T1DM versus Immigrant T1DM by assessing hospital admissions [Aim 1]

Origin-stratified case control [Case (T1DM) vs double control (healthy), italian and immigrant: evaluation microbiota/metabolic profile, vit D] [Aim 2]

Prospective cohort study (TDM1 italian vs TDM1 immigrant: evaluation of the impact of social and health-related factors) [Aim 3]

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cases migrants : T1DM's recent diagnosis
  • Italian cases : comparable to individual characteristics, living area, mainly age and gender
  • Controls: healthy children (two control comparable for each case)

Exclusion criteria

  • Children with parents of mixed origin
  • Children with chronic gastrointestinal disorders (such as irritable bowel syndrome) or other relevant metabolic or systemic co-morbility
  • Children who used antibiotics or with diarrhea in the last 15 days

Treatment and study plan

Primary outcomes

  1. Metabolic control

    Time frame: at onset

    The blood pH of the patients are measured at the onset to define ketoacidosis following normal standard hospital procedure.

Secondary outcomes

  1. Body mass index

    Time frame: at onset

    calculated as (weight (kg))/(height (meters))exp2

  2. Glycated hemoglobin

    Time frame: at onset

    in % and as mmol/mol

  3. Diet behaviour

    Time frame: at onset

    The 24h-recall technique reconstructed meals and food intake on a recent "typical" day, estimating, under a bromatology point of vie, inputs according to food composition database for epidemiological studies in Italy (BDA)

  4. vitamin D

    Time frame: at the onset

    evaluated from serum sample as 25-hydroxyvitamin D (ng/ml)

  5. Microbiome bioindicators

    Time frame: at onset

    The Denaturing Gradient Gel Electrophoresis profile was evaluated for each patients starting from the stool sample. Shannon index is calculated (theory range from 0 to infinite; in literature from 0.1 to 4)

  6. Methanobrevibacter smithii

    Time frame: at onset

    Starting from the stool DNA extracted, following bioindicator measured by quantitative Real Time Polymerase Chain Reaction: Methanobrevibacter smithii (num gene copies - both as 16S ribosomal RNA gene and nifH gene /g stool)

  7. Akkermansia muciniphila quantification in stool

    Time frame: at onset

    Starting from the stool DNA extracted, following bioindicator measured by quantitative Real Time Polymerase Chain Reaction : Akkermansia muciniphila (num copies 16SrDNA /g stool)

Other outcomes

  1. Metabolic control 2

    Time frame: at onset

    The blood carbonate of the patients are measured at the onset to define ketoacidosis

Sponsors and collaborators

Lead sponsor

University of Turin, Italy

Other

Collaborators

  • A.O.U. Città della Salute e della Scienza
  • Azienda Ospedaliero Universitaria Maggiore della Carita

Registry information

Official study title

Determinants of Type 1 Diabetes (T1DM) Clinical Onset and Progression in Paediatric Immigrant Population

Acronym: Bioda

Important dates

Study start
2015
Primary completion
2017
Study completion
2018
First posted
Jun 6, 2018
Registry last updated
Dec 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.